ID   MCRIi001-A-2
AC   CVCL_WU54
SY   MCRIi001-A-SOX9tdTom; PB001-SOX9tdTom
DR   BioSamples; SAMEA5873308
DR   hPSCreg; MCRIi001-A-2
DR   Wikidata; Q95986993
RX   PubMed=31884373;
RX   PubMed=32446218;
RX   PubMed=32771907;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 SOX9 has been endogenously tagged at the C-terminus with TdTomato.
CC   Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK82 ! MCRIi001-A
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
RX   PubMed=31884373; DOI=10.1016/j.scr.2019.101689;
RA   Nur Patria Y., Lilianty J., Elefanty A.G., Stanley E.G., Labonne T.,
RA   Bateman J.F., Lamande S.R.;
RT   "Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2,
RT   using CRISPR/Cas9 editing.";
RL   Stem Cell Res. 42:101689-101689(2020).
//
RX   PubMed=32446218; DOI=10.1016/j.scr.2020.101843;
RA   Lilianty J., Nur Patria Y., Stanley E.G., Elefanty A.G., Bateman J.F.,
RA   Lamande S.R.;
RT   "Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal
RT   dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9
RT   gene editing.";
RL   Stem Cell Res. 45:101843-101843(2020).
//
RX   PubMed=32771907; DOI=10.1016/j.scr.2020.101942;
RA   Nur Patria Y., Stenta T., Lilianty J., Rowley L., Stanley E.G.,
RA   Elefanty A.G., Bateman J.F., Lamande S.R.;
RT   "CRISPR/Cas9 gene editing of a SOX9 reporter human iPSC line to
RT   produce two TRPV4 patient heterozygous missense mutant iPSC lines,
RT   MCRIi001-A-3 (TRPV4 p.F273L) and MCRIi001-A-4 (TRPV4 p.P799L).";
RL   Stem Cell Res. 48:101942-101942(2020).
//